Michael David Garrison Becton Dickinson & CO (BDX) insider trading activity

Michael David Garrison is EVP & Pres Med.Essntl&BioPharm of BECTON DICKINSON & CO. Currently has a direct ownership of 12,095 shares of BDX, which is worth approximately $2.31 Million. The most recent transaction as insider was on Jan 15, 2026, when has been sold 1,610 shares (Common Stock) at a price of $207.77 per share, resulting in proceeds of $334,509. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.1K

147.49% 3M change

118.16% 12M change

Total Value Held $2.31 Million

Michael David Garrison Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 15 2026	SELL Open market or private sale	$334,509 $207.77 p/Share	1,610 Reduced 11.75%	12,095 Common Stock
Jan 15 2026	SELL Sale (or disposition) back to the issuer	$512,886 $209.0 p/Share	2,454 Reduced 15.19%	13,705 Common Stock
Jan 15 2026	BUY Exercise of conversion of derivative security	$512,797 $167.91 p/Share	3,054 Added 15.9%	16,159 Common Stock
Dec 17 2025	SELL Open market or private sale	$123,302 $196.03 p/Share	629 Reduced 4.58%	13,105 Common Stock
Nov 26 2025	SELL Payment of exercise price or tax liability	-	1,769 Reduced 11.41%	13,734 Common Stock
Nov 26 2025	BUY Grant, award, or other acquisition	-	10,616 Added 40.64%	15,503 Common Stock
Jul 18 2025	SELL Open market or private sale	$214,354 $180.89 p/Share	1,185 Reduced 19.52%	4,887 Common Stock

Jul 18 2025	SELL Sale (or disposition) back to the issuer	$933,000 $180.29 p/Share	5,175 Reduced 46.01%	6,072 Common Stock
Jul 18 2025	BUY Exercise of conversion of derivative security	$939,244 $147.68 p/Share	6,360 Added 36.12%	11,247 Common Stock
Apr 09 2025	SELL Open market or private sale	$94,497 $197.28 p/Share	479 Reduced 8.93%	4,887 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	-	178 Reduced 3.21%	5,366 Common Stock
Jan 17 2025	SELL Open market or private sale	$141,196 $236.51 p/Share	597 Reduced 9.72%	5,544 Common Stock
Dec 19 2024	SELL Open market or private sale	$633,810 $223.33 p/Share	2,838 Reduced 31.61%	6,141 Common Stock
Nov 26 2024	SELL Payment of exercise price or tax liability	-	1,230 Reduced 12.05%	8,979 Common Stock
Nov 26 2024	BUY Grant, award, or other acquisition	-	4,828 Added 32.11%	10,209 Common Stock
Apr 30 2024	SELL Open market or private sale	$399,269 $232.81 p/Share	1,715 Reduced 24.17%	5,381 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	-	178 Reduced 2.45%	7,096 Common Stock
Dec 11 2023	SELL Open market or private sale	$288,017 $232.46 p/Share	1,239 Reduced 14.55%	7,274 Common Stock
Nov 26 2023	SELL Payment of exercise price or tax liability	-	1,646 Reduced 16.2%	8,513 Common Stock
Nov 26 2023	BUY Grant, award, or other acquisition	-	5,002 Added 32.99%	10,159 Common Stock
Aug 08 2023	SELL Open market or private sale	$360,269 $277.13 p/Share	1,300 Reduced 20.13%	5,157 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	-	193 Reduced 2.9%	6,457 Common Stock
Nov 26 2022	SELL Payment of exercise price or tax liability	-	617 Reduced 8.49%	6,650 Common Stock
Nov 26 2022	BUY Grant, award, or other acquisition	-	2,790 Added 27.74%	7,267 Common Stock

MDG

Michael David Garrison

EVP & Pres Med.Essntl&BioPharm

Franklin Lakes, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDX shares.

Notify only if

Value

Insider Trading

Get notified when an Becton Dickinson & CO insider buys or sells BDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BECTON DICKINSON & CO

Track Activities on BDX

Account